NEW YORK, May 1, 2017 /PRNewswire/ -- While today's medical advances have created new effective therapeutic pathways to treat cancer, these aggressive treatments can have noticeable, negative effects on the skin, scalp and/or nails. Two out of three cancer patients suffer from these types of cutaneous side effects1, which in turn, can truly take a toll on his or her quality of life2. Although the key objective of treatment is to cure, quality of life is also crucial for those with cancer. Fortunately, these expected changes both during and after treatment can be relieved and sometimes prevented with tailored therapeutic regimens and dermo-cosmetic care3.
La Roche-Posay, a trusted source for skincare worldwide, is pleased to partner with the George Washington University Cancer Center to launch the GW Supportive Oncodermatology Clinic, with the first patients to be seen in mid-May at the GW Medical Faculty Associates. Under the leadership of Dr. Adam Friedman, Associate Professor of Dermatology, Residency Program Director, and Director of Translational Research in the Department of Dermatology, the clinic will serve the comprehensive dermatologic needs of cancer patients by addressing the broad range of issues that occur during and after treatment. Furthermore, Dr. Friedman and his team will provide valuable expert skincare advice, educational materials, and La Roche-Posay skincare samples to help alleviate and manage the side effects caused by cancer treatment. This type of oncodermatology program with La Roche-Posay currently exists with many hospitals in Europe under Better Skin Throughout Cancer.
"This is a great example of how academia and industry can partner together in a meaningful way to target a common mission, in this case, to improve both the quality of life of those being treated and managed for all forms of cancer and their ongoing care in collaboration with our colleagues in Oncology," shares Dr. Friedman.
Rooted in a commitment to dermatology, La Roche-Posay has a long history of supporting the needs of even the most sensitive skin. In 1905, the Thermale Connetable Thermal Hospital opened above a unique aquaphor in the French town of La Roche-Posay. Enriched with unique minerals and antioxidants, the water proved to have soothing properties to the skin. Throughout the years, thousands of adults and children have received various thermal treatments, making it the top European dermatological thermal center for serious skin conditions. Thanks to the virtues of the Thermal Spring Water, post-cancer patients have also received treatments to soothe their sensitive skin conditions.
In 1975, La Roche-Posay first formulated products using the proprietary Thermal Spring Water that could be used alongside treatment. Since then, La Roche-Posay has become a leading player in the development of products safe enough and formulated for even the most sensitive skin types, testing for tolerance and safety. The proprietary Thermal Spring Water is at the heart of La Roche-Posay skincare products, making the therapeutic ingredient available to all. Through La Roche-Posay's ESKIMO group (European Skin Management in Oncology,) a panel of dermatologists and an oncologist specialized in treating both dermatological problems and cancer analyze and propose appropriate skincare product recommendations for patients receiving either chemotherapy or radiotherapy.
In addition to the physiology of sensitive skin, La Roche-Posay has delved deeply into the psychological effects that the condition has on its sufferers taking into consideration the disabling impact on self-esteem and social activities. As such, La Roche-Posay formulates its products to not only treat the signs of sensitive skin, but improve the quality of life for its sufferers, in particular those undergoing harsh cancer treatment. The skincare brand recommended by dermatologists worldwide reaffirms its commitment to dermatology by providing solutions that not only improve the quality of life for those with skin sensitivities, but deliver truly efficacious results.
About LA ROCHE-POSAY
Recommended by more than 25,000 dermatologists worldwide, La Roche-Posay offers a unique range of daily skincare developed with dermatologists for every skin type to complement and enhance their patients' treatments and to promote good skincare practices at home every day. Started from Europe's leading center of thermal dermatology, La Roche-Posay develops formulas with its exclusive Selenium-rich water, used at the center since 1905, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated with ingredients at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin.
For additional information about La Roche-Posay, visit www.laroche-posay.us and follow La Roche-Posay USA on Facebook, Instagram and Twitter @LaRochePosayUSA
1 Study IGR L'Oreal R&I
2 Study IGR L'Oreal R&I
3 L'Oreal R&Algorithm for dermocosmetic use in the management of cutaneous side effects associated with targeted therapy in oncology» published by the Journal of the European Academy of Dermatology & Venereology and Breast Cancer: Targets and Therapy
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/la-roche-posay-supports-the-oncodermatology-clinic-at-george-washington-university-300448818.html
SOURCE La Roche-Posay